However, Claudin-2 is selectively enriched in breast cancer liver metastases, and high Claudin-2 expression in primary breast tumors is associated with liver-specific metastatic recurrence (Tabariès et al. 2011; Kimbung et al. 2014). Here, CLDN2 is linked to breast neoplasm.